BackEucrates Biomedical Acquisition - Warrants (23/10/2027) Overview

Eucrates Biomedical Acquisition - Warrants (23/10/2027) Total Current Liabilities

Latest total current liabilities for EUCRW: $65K.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$65140.00

Peer average

Loading

Eucrates Biomedical Acquisition - Warrants (23/10/2027) Total Current Liabilities History

Loading

Eucrates Biomedical Acquisition - Warrants (23/10/2027) vs. peers: Total Current Liabilities Comparison

Loading

Eucrates Biomedical Acquisition - Warrants (23/10/2027) Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Eucrates Biomedical Acquisition - Warrants (23/10/2027) (EUCRW) FAQ

The latest total current liabilities for EUCRW is $65K as of December 2022. In the prior-year period, the figure was $0. Investors often review this figure alongside Eucrates Biomedical Acquisition - Warrants (23/10/2027)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, EUCRW's total current liabilities moved from $0 to $65K. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Eucrates Biomedical Acquisition - Warrants (23/10/2027)'s operating scale or balance-sheet position.

A total current liabilities figure of $65K for EUCRW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting EUCRW's total current liabilities ($65K), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.